Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

CONTEXT: In the absence of an effective vaccine, serogroup B Neisseria meningitidis (MenB) remains a major cause of invasive disease in early childhood in developed countries. OBJECTIVE: To determine the immunogenicity and reactogenicity of a multicomponent MenB vaccine (4CMenB) and routine infant v...

Full description

Bibliographic Details
Main Authors: Gossger, N, Snape, MD, Yu, L, Finn, A, Bona, G, Esposito, S, Principi, N, Diez-Domingo, J, Sokal, E, Becker, B, Kieninger, D, Prymula, R, Dull, P, Ypma, E, Toneatto, D, Kimura, A, Pollard, A
Format: Journal article
Language:English
Published: 2012